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INTRODUCTION
Human immunodeficiency virus (HIV) infection is
known to be associated with various types of glomerulone-
phritis. Human immunodeficiency HIV – associated kidney
diseases have been classified into 3 different groups: HIV-
associated nephropathy (HIVAN), also known as HIV-asso-
ciated focal and segmental glomerulosclerosis (HIV-FSGS),
hemolytic-uremic syndrome (HIV-HUS), and HIV-associated
immune complex renal diseases.1,2 Previously thought to be
rare, these forms of glomerulonephritis have become more
frequent, and it is important that the medical community
learns more about its diagnosis and treatment.
Case description
A Caucasian 34-year-old man was referred to our clinic
due to an acute loss of kidney function. A diagnosis of HIV
infection was made 3 years before the patient had been un-
der regular follow-up at the Infectious Desease Department
since then. The last CD4 count (3 months before consulta-
tion) was 374 cells/µL, and the HIV viral load was 1350
000 copies/mL (6.1 log). He was not on anti-retroviral
therapy and had never presented any opportunistic infec-
tion. There was no history of diabetes, hypertension, kid-
ney disease, or any other remarkable comorbidity. There
was also no history of intravenous drug use or exposure to
any nephrotoxic drugs.
Four to five weeks before consultation, he started to
have asthenia. He reported no other symptoms, except for
foamy urine. One week before consultation, he presented
fever and dry cough, with a normal chest X-ray, and was
started on azitromycin 500 mg/day and prophylaxis with
sulfamethoxazole-trimethoprim. His laboratory test results
on this day revealed a creatinine level of 1.8 mg/dL, dis-
crete anemia, hematuria, and nephrotic-range proteinuria
(Table 1). Creatinine and urinalysis 3 months before were
normal.
On the day he was first seen in our clinic, physical ex-
amination revealed a healthy appearance, a blood pressure
of 120 x 70 mm Hg, normal temperature, pulse of 66 beats
per minute, and no signs of edema. Chest, heart, and ab-
dominal examination showed no abnormalities. Cough and
fever had vanished, and the patient was feeling well. His
new laboratory results demonstrated a rapid worsening in
renal function, with a creatinine value of 3.2 mg/dL (an
interval of 1 week after the first test results, Table 1). The
24-hour urine collection confirmed a nephrotic range pro-
teinuria of 4.5 g/day. Serum albumin was 2.2 mg/dL; total
cholesterol was 192 mg/dL; LDL-cholesterol, 52 mg/dL;
HDL-cholesterol, 78 mg/dL; and triglycerides, 309 mg/dL.
A discrete anemia was noticed, with a normal mean cor-
puscular volume, serum iron concentration of 90 µg/dL, and
ferritin of 1882 µg/dL. Despite a high LDH, not confirmed
Table 1 - Results of laboratory tests.
One week before On admission
Urea (mg/dL) 89 91
Creatinine (mg/dL) 1.8 3.2
Sodium (mEq/L) 141
Potassium (mEq/L) 4.7 6.8
Hemoglobin (g/dL) / Hematocrit (%) 10.6 / 32 10.2 /32
White cell count (per mm3) 4860 4250
Platelet count (per mm3) 225 000 207 000
Lactate dehydrogenase (U/L) 922 927
Albumin / Globulins (mg/dL) 2.2 / 3.1
Glucose (mg/dL) 94
Urinalysis
Leukocytes (per field) 2 2
Erythrocytes (per field) 10 12
Protein (g/L) > 1 > 1
24h-proteinuria g/day 4.52
Erythrocyte sedimentation rate (mm) 114
C reactive protein (mcg/mL) 2.42
C4 (mg/dL) 24
C3 (mg/dL) 103
Normal reference range: lactate dehydrogenase, 240-480 U/L; CRP,
< 5 mcg/mL; C3, 90-180 mg/dL; C4, 10-40 mg/dL.
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subsequently, there was no other laboratory evidence of
thrombotic microangiopathy, since there was no sign of
schistocytes in the blood smear and the haptoglobin level
was normal. Hepatitis B serology revealed positive anti-Hbe
and total antiHbc antibodies, with negative results for
AgHbs, AgHbe, anti-Hbs, and IgM anti-Hbc. Hepatitis C
serology and tests for antinuclear and anti-neutrophil cy-
toplasm antibodies were negative, and the complement lev-
els were normal.
He was admitted in the nephrology ward and underwent
a kidney biopsy.
Kidney biopsy
Light microscopic analysis of a specimen containing 5
glomeruli showed mesangial hypercellularity, an epithelial
crescent in 1 glomerulus, tubular focal atrophy with thick-
ening and shrinking of the tubular basal membrane, and
fibrosis on 40% of the interstitial space. Immunofluores-
cence demonstrated granular deposits of IgM and C3 in the
mesangium. Electron microscopy revealed expansion of the
mensagial matrix, hypertrophy and cytoplasmatic vacuoli-
zation of mensagial cells, thickening and segmental split-
ting of the basal membrane, and hypertrophy and
vacualization of podocytes, with diffuse fusion of podocyte
foot processes. Electron-dense deposits were noted on the
mesangium and subendothelial spaces, and abundant
tubuloreticular inclusions were present in the cytoplasm of
endothelial cells. Immunohistochemistry for hepatitis B was
negative.
Diagnosis: HIV-associated immune complex-mediated
glomerulonephritis with a membranoproliferative pattern.
DISCUSSION
Among HIV-associated kidney diseases, HIV-FSGS
seems to be the most common form of HIV
glomerulopathy. In the United States, this disease is increas-
ing in prevalence, and there is a higher risk among patients
of the black race. Recent reports suggest that the same pat-
tern is not observed in various European countries, with a
higher proportion of cases attributed to HIV-HUS and im-
mune-mediated glomerulonephritis.3,4 Although there is
lack of epidemiological data concerning other parts of the
world, the incidence of HIV-FSGS in African descendents
outside the US does not seem to be so high.5
HIV-associated nephropathy can occur in any phase of
the HIV infection, including acute seroconversion, but is
usually seen later in the disease, when viral load is higher.
The clinical picture is that of massive nephrotic syndrome,
although edema and hypertension are generally absent. Pa-
tients can also present non-nephrotic range proteinuria as-
sociated with a variable loss of kidney function. Kidney
biopsy usually shows a severe form of FSGS, frequently
with characteristics of the collapsing form (severe shrink-
ing of the glomerulus accompanied by microcystic tubular
dilation). Tubuloreticular inclusions are universally seen,
usually located in the cytoplasm of endothelial cells. HIV-
associated focal and segmental glomerulosclerosis carries
a poor prognosis and is currently the leading cause of end-
stage renal disease due to HIV in US.6 Treatment is based
on viral load control involving highly active antiretroviral
therapy (HAART) associated with use of angiotesin-con-
verting enzyme (ACE) inhibitors. The beneficial impact of
ACE inhibitors in HIV-FSGS was shown in 2
nonrandomized case-control studies,7,8 showing reduction
of proteinuria and improvement in renal function. More
controversial is the use of corticosteroids, with lack of evi-
dence-based data. Although there are reports of improve-
ment of proteinuria and renal function with corticosteroids,
a high recurrence rate of nephrotic syndrome and an in-
crease in infectious-associated morbidity and mortality are
still a concern.
HIV has become an important cause of HUS-TTP
worldwide. The clinical picture is that of typical hemolytyc
anemia associated with low platelet count and an increase
in biomarkers of hemolysis (LHD, indirect bilirrubin, low
haptoglobin). A discrete consuming of complement might
be seen as a result of microangiopathy. The renal manifes-
tation is variable, and the disease can present as an acute
glomerulonephritis with sudden loss of kidney function, or
as a more indolent nephropathy, characterized mainly by
non-nephrotic proteinuria and mild-to-moderate renal in-
sufficiency. The kidney pathology is no different from other
Figure 1 - Kidney biopsy: Panel A shows extensive fibrosis, appearing in
trichrome stain (1,25×) as green areas. Panel B (Masson stain - 400×) shows
global hipercelularity, mostly of mesangial cells and a cellular crescent
formation on the right side (arrow). Panel C shows a silver stain exhibiting
occasional double contours of the glomerular basement membrane (arrox -
400×). Panel D reveals a high power electron micrograph abundant
tubuloreticular inclusions in the cytoplasm of glomerular endothelial cells.
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forms of renal microangiopathy: platelet and fibrin thrombi
in capillaries and renal arterioles, intimal lesion, fibrinoid
necrosis, and mesangiolysis due to ischemia of the
glomerulus are all histological features. Typical “onion
skin” lesions of microangiopathy might be seen. Immun-
ofluorescence is usually positive for fibrin and fibrinogen,
but low positivity for complement fractions and IgM might
be present. Tubuloreticular inclusions are also seen, mainly
in vascular endothelial cells.
Previously thought to be extremely rare, diverse forms
of HIV-associated immune complex glomerulonephritis
have recently been described more frequently. Typical
postinfectious acute glomerulonephritis, membranous
glomerulonephritis, membranoproliferative glomerulone-
phritis, lupus-like glomerulonephritis, IgA nephropathy, and
fibrillary glomerulonephritis3,4,9-11 have all been described.
Of those, membranoproliferative glomerulonephritis and
lupus-like nephritis seem to be the most common forms.
It is possible that the variability in renal histology pat-
terns observed is a result of the interaction between host
environmental and genetic factors and a broad spectrum of
immunogenicity triggered by the virus. The pathophysi-
ological mechanisms underlying the renal insult remain
largely unknown. Direct cytopathic effect, expression of
intracellular antigens and deposition of in situ immune
complexes, abnormal activation of the immune system with
formation of circulating immune complexes, and subse-
quent renal deposition are all possible explanations.12
In this present case, renal pathology showed an acute
glomerulonephritis, with signs of splitting of the basement
membrane and the appearance of double contours. This his-
tological pattern associated with the presence of
tubuloreticular inclusions suggests the diagnosis of HIV-
associated immune complex glomerulonephritis.
Tubuloreticular inclusions have been described in all forms
of HIV-nephritis, from HIVAN, to HUS and immune com-
plex glomerulonephritis. In fact, these inclusions have been
described in many organs affected by HIV, and their ap-
pearance seems to have a correlation with viral load and
disease progression. Despite the initial assumption that
these inclusions were composed of viral particles, later
studies13-14 suggest that they are related to interferon pro-
duction. Tubuloreticular inclusions (TRI) are not pathog-
nomonic of HIV, although they appear very frequently in
this disease: autoimmune diseases (SLE15, dermatomyosi-
tis), lymphoproliferative disease, certain solid tumors, and
other viral diseases (parvovirus, Epstein-Barr) have also
been associated with these inclusions, suggesting that TRI
are probably an immunological epiphenomenon of several
diseases.
This case illustrates very nicely how broad the differ-
ential diagnosis of HIV-related nephritis can be. This pa-
tient was Caucasian, had a CD4 count of 374, and no his-
tory of opportunistic infections or drug exposure, and he
developed a severe and aggressive form of acute glomeru-
lonephritis. Diagnosis could not be established on clinical
and laboratory data, and kidney biopsy was crucial to di-
agnosis, treatment decision, and prognosis. This case em-
phasizes that although HIVAN and HUS are the most com-
mon forms of HIV-related kidney diseases, we need to con-
sider the immune complex glomerulonephritis as alterna-
tive diagnosis.
It might be argued that hepatitis B could be responsi-
ble for the acute glomerulonephritis, since the patient has
not shown seroconversion to anti-AgHbs. It is known that
a few patients with serology showing negative results for
AgHbs, AgHbe, and anti-Hbs can have a positive viral load
for hepatitis B detected by qualitative assays for detecting
serum HBV DNA. More importantly, interpretation of
hepatitis B serology is more complicated in HIV patients,
since a fall in CD4 is associated with a risk of hepatitis B
replication, while antiviral treatment for HIV might cause
a reduction in HBV viral load. Although we could not per-
form a polymerase chain reaction (PCR) test for hepatitis
B in this case, immunohistochemistry was negative for
hepatitis B, suggesting that hepatitis B virus was not asso-
ciated with the appearance of the glomerulonephritis in this
case.
Our patient was started on HAART associated with ACE
inhibitors. Considering the good clinical condition of the
patient and absence of previous or current opportunistic in-
fections, we also started oral 1 mg/kg prednisone for 1
month, with full tapering after 3 months. There was a marked
improvement in renal function, with a current creatinine of
1.3 mg/dL (creatinine clearance of 60 mL/min), but no re-
gression of proteinuria (4.3 g/day) after 3 months of treat-
ment. After 1 year of follow-up, creatinine clearance was 73
mL/min and proteinuria was reduced to 1 g/day.
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